Schonfeld Strategic Advisors LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 67 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,108,000
-17.4%
289,179
+13.6%
0.02%
-18.5%
Q2 2021$2,551,000
-35.7%
254,603
-38.8%
0.03%
-43.8%
Q1 2021$3,970,000
+814.7%
415,692
+748.9%
0.05%
+500.0%
Q3 2020$434,00048,9700.01%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 3,567,985$8,491,8042.58%
Aisling Capital Management LP 1,043,267$2,482,9751.02%
Atom Investors LP 156,168$371,6800.08%
Pentwater Capital Management LP 5,975,000$14,220,5000.08%
CORNERCAP INVESTMENT COUNSEL INC 79,709$189,7070.04%
Forefront Analytics, LLC 24,969$59,4280.03%
Callan Capital, LLC 76,559$182,2100.02%
XTX Topco Ltd 40,782$97,0610.02%
Advisory Services Network, LLC 257,271$612,3050.02%
RBF Capital, LLC 70,171$167,0070.01%
View complete list of POSEIDA THERAPEUTICS INC shareholders